-

Cresco Labs to Report Second Quarter 2023 Financial Results on August 16, 2023

CHICAGO--(BUSINESS WIRE)--Cresco Labs (CSE:CL) (OTCQX:CRLBF) (FSE: 6CQ) (“Cresco” or “the Company”), a vertically integrated, multi-state operator and the cannabis industry’s No. 1 producer of branded products, today announced it will report financial results for the second quarter 2023 on Wednesday, August 16th, 2023 before the market opens.

The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights.

Event:

Cresco Labs Second Quarter 2023 Earnings Conference Call

Date:

Wednesday, August 16th, 2023

Time:

8:30 am EST

Webcast:

Link

Dial-in:

1-833-470-1428 (US Toll Free), 1-404-975-4839 (US Local)

Access Code:

979042

Archived access to the webcast will be available for one year on the Cresco Labs investor relations website.

About Cresco Labs

Cresco Labs is one of the largest vertically integrated, multi-state cannabis operators in the United States, with a mission to normalize and professionalize the cannabis industry. Employing a consumer-packaged goods (“CPG”) approach, Cresco Labs is the largest wholesaler of branded cannabis products in the U.S. Its brands are designed to meet the needs of all consumer segments and comprised of some of the most recognized and trusted national brands including Cresco®, High Supply®, Mindy’s™, Good News®, Remedi™, Wonder Wellness Co.® and FloraCal Farms®. Cresco Labs’ national dispensary brand, Sunnyside®, is a wellness-focused retailer created to build trust, education and convenience for both existing and new cannabis consumers. Recognizing that the cannabis industry is poised to become one of the leading job creators in the country, Cresco Labs operates the industry’s largest Social Equity and Educational Development initiative, SEED™, which was established to ensure that all members of society have the skills, knowledge and opportunity to work and own businesses in the cannabis industry. Learn more about Cresco Labs at www.crescolabs.com.

Facebook: Cresco Labs

Instagram: Cresco Labs

Twitter: Cresco Labs

Contacts

Media:
Jason Erkes, Cresco Labs
Chief Communications Officer
press@crescolabs.com

Investors:
Megan Kulick, Cresco Labs
Senior Vice President, Investor Relations
investors@crescolabs.com

For general Cresco Labs inquiries:
312-929-0993
info@crescolabs.com

Cresco Labs

CNSX:CL

Release Summary
CRESCO LABS TO REPORT SECOND QUARTER 2023 FINANCIAL RESULTS ON AUGUST 16, 2023
Release Versions

Contacts

Media:
Jason Erkes, Cresco Labs
Chief Communications Officer
press@crescolabs.com

Investors:
Megan Kulick, Cresco Labs
Senior Vice President, Investor Relations
investors@crescolabs.com

For general Cresco Labs inquiries:
312-929-0993
info@crescolabs.com

Social Media Profiles
More News From Cresco Labs

Cresco Labs CEO: Rescheduling Ushers in a New Era of Care for Medical Cannabis Patients

CHICAGO--(BUSINESS WIRE)--Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco Labs” or the “Company”), today issued a statement on behalf of Cresco Labs CEO Charlie Bachtell in response to the Department of Justice’s final rule publication rescheduling medical cannabis from Schedule I to Schedule III under the Controlled Substances Act. “Rescheduling medical cannabis is a long-overdue step that finally brings federal policy closer to the science. For the first time in history, our fed...

Cresco Labs to Report First Quarter 2026 Financial Results on May 8, 2026

CHICAGO--(BUSINESS WIRE)--Cresco Labs Inc. (CSE:CL) (OTCQX:CRLBF) (FSE: 6CQ) (“Cresco” or “Company”), the industry leader in branded cannabis products with a portfolio of America’s most popular brands and the operator of Sunnyside dispensaries, today announced it will report financial results for the quarter ended March 31st, 2026 on Friday, May 8, 2026 before the market opens. The Company will host a conference call and webcast to discuss its financial results and provide investors with key bu...

Cresco Labs Opens Sunnyside Bridgeport, Expanding Access in the Ohio Valley

CHICAGO--(BUSINESS WIRE)--Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco Labs” or the “Company”), today announced the grand opening of Sunnyside Bridgeport, located at 435 Main Street in Bridgeport, Ohio. It’s the Company’s seventh dispensary in Ohio and 73rd nationwide. “We’re proud to join the Bridgeport community and offer a positive, reliable shopper experience to the people of Belmont County,” said Charlie Bachtell, CEO of Cresco Labs. “Ohio is an important market for Cresco...
Back to Newsroom